Kepos Capital’s Veracyte VCYT Stock Holding History

Kepos Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,979	Closed	-$390K	–	311
2019 Q4	$390K	Sell	13,979 -2,963	-17%	-$76.7K	0.04%	255
2019 Q3	$407K	Buy	+16,942	New	+$451K	0.04%	220

Other funds holding VCYT

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kepos Capital's VCYT Position: Q1 2020 in Review

Kepos Capital sold out of Veracyte (VCYT) in Q1 2020, closing a stake of 13,979 shares — an estimated $390K sold.

Kepos Capital first reported a position in VCYT in Q3 2019 and held it in 2 quarters. The position peaked at $407K in Q3 2019. 165 funds tracked by Wall St. Rank hold VCYT as of Q1 2020.

Kepos Capital reported no remaining Veracyte position as of Q1 2020 after selling out during the quarter.
Kepos Capital sold 13,979 Veracyte shares in Q1 2020, an estimated $390K.
Kepos Capital first reported a position in Veracyte in Q3 2019 and held it in 2 quarters.
Kepos Capital's Veracyte position peaked at $407K in Q3 2019.
165 funds tracked by Wall St. Rank held Veracyte as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.